Trucks with 1st COVID-19 vaccine for Americans roll out of Michigan

The first trucks carrying a COVID-19 vaccine for widespread use in the U.S. pulled out of a Michigan manufacturing plant on Sunday, with the shots that are critical to battling the pandemic destined to reach states a day later.

Health workers, nursing home residents priority recipients of Pfizer-BioNTech shot

Boxes containing the Pfizer-BioNTech COVID-19 vaccine are prepared to be shipped from the Pfizer manufacturing plant in Portage, Mich., on Sunday. (Morry Gash/The Associated Press)

The first trucks carrying a COVID-19 vaccine for widespread use in the United States pulled out of a Michigan manufacturing plant on Sunday, with the shots that are critical to stopping the nation's coronavirus outbreak destined to reach states a day later.

An assembly line of workers began in the early morning hours pulling doses out of a freezer, boxing the vaccine and loading the units onto pallets so they could be placed on trucks at the Pfizer plant near Kalamazoo, Mich. Dry ice, shipping labels and packing tape were on hand as the workers — donning masks, face shields and gloves — put together the packages inside the warehouse.

One forklift driver transported the boxes to a loading area, where a second forklift driver was transferring the pallets from inside the facility onto a semi-truck. Workers in the plant cheered after the packages were loaded onto delivery trucks, as did area residents outside the facility.

Shipments of the Pfizer vaccine will set in motion the biggest vaccination effort in American history at a critical juncture of the pandemic, which has killed 1.6 million people and sickened 71 million worldwide.

Initially, about three million doses were expected to be sent out, and the priority is health-care workers and nursing home residents as infections, hospitalizations and deaths soar in the U.S. With numbers likely to get worse over the holidays, the vaccine is offering a bright spot in the fight against the pandemic, which as killed nearly 300,000 Americans.

Nancy Galloway, left, and Susan Deur cheer as trucks carrying the first shipment of the Pfizer-BioNTech COVID-19 vaccine, escorted by the U.S. Marshals Service, leave Pfizer's Global Supply facility near Kalamazoo, Mich., on Sunday. (Jeff Kowalsky/AFP via Getty Images)

Federal officials say the first shipments of Pfizer's vaccine will be staggered, arriving in 145 distribution centres on Monday, with an additional 425 sites getting shipments on Tuesday and the remaining 66 on Wednesday. The vaccine, co-developed with German partner BioNTech, is being doled out based on each state's adult population.

Pennsylvania health-care giant UPMC has chosen staff who are critical to operating its facilities as among those getting the first round of vaccinations, said Dr. Graham Snyder, who led the centre's vaccine task force.

"It's very exciting. I will be thrilled, that moment when we administer our first dose," he said Saturday. "That will clearly be a watershed moment for us."

Snyder said the UPMC system estimates that half its employees are willing to get the vaccine as soon as it's offered to them.

Extreme cold needed for transport

The vaccine is heading to hospitals and other sites that can store it at extremely low temperatures — below –70 C. Pfizer is using containers with dry ice and GPS-enabled sensors to ensure each shipment stays colder than the weather in Antarctica.

WATCH | COVID-19 vaccine doses shipped across U.S.

COVID-19 vaccine doses shipped across U.S.

10 months ago
The first shipments of the Pfizer-BioNTech COVID-19 vaccine have been sent across the United States, with the first doses expected to be given out on Monday as the country's death toll approaches 300,000. 1:59

Doses should be delivered to all vaccination sites identified by states, such as local pharmacies, within three weeks, federal officials said.

The 40-hospital Ochsner Health System in Louisiana and Mississippi expects to receive more than 9,000 doses in the coming days, said Dr. Sandra Kemmerly, medical director of hospital quality.

Employees approved for the first round are getting texts and emails directing them to schedule their initial injection, she said.

"I would say there's enthusiasm," Kemmerly said Saturday. "There's that thought that maybe they don't have to be so afraid to come to work if they can be vaccinated and be immune."

The rollout will ensure there is enough vaccine to give people the two doses needed for full protection against COVID-19. That means the government is holding back three million doses to give those vaccinated in the first round a second shot a few weeks later.

The Food and Drug Administration authorized emergency use of the vaccine on Friday, saying it is highly protective and presents no major safety issues. While U.S. regulators worked for months to emphasize the rigour and independence of their review, they faced political pressure until the final stages.

WATCH | Canadian officials hope to reassure those reluctant to get COVID-19 vaccine:

Health officials hope to reassure those reluctant to get COVID-19 vaccine

11 months ago
While doses of a COVID-19 vaccine are still months away for most Canadians, health officials are already working on ways to allay concerns some people have about how quickly vaccines were developed. The Public Health Agency of Canada acknowledges there’s a ‘sizeable minority’ with reservations, but says it's committed to making sure Canadians know they will be safe. 2:05

Concerns that a shot was rushed out could undermine vaccination efforts in a country with deeply ingrained skepticism about vaccines. The head of the FDA said the agency's decision was based on science, not politics, despite a White House threat to fire him if the vaccine wasn't approved before Saturday.

While the vaccine was determined to be safe, regulators in the U.K. are investigating several severe allergic reactions. The FDA's instructions tell providers not give it to those with a known history of severe allergic reactions to any of its ingredients.

Another vaccine by Moderna will be reviewed by an expert panel this week and soon afterward could be allowed for public use.

Add some “good” to your morning and evening.

A variety of newsletters you'll love, delivered straight to you.

Sign up now


To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.

Become a CBC Member

Join the conversation  Create account

Already have an account?